Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients
Open Access
- 3 April 2014
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 39 (10) , 2349-2356
Abstract
Bipolar disorder (BD) is characterized by mood swings between manic and depressive states. The etiology and pathogenesis of BD is unclear, but many of the affected cognitive domains, as well as neuroanatomical abnormalities, resemble symptoms and signs of small vessel disease. In small vessel disease, cerebrospinal fluid (CSF) markers reflecting damages in different cell types and subcellular structures of the brain have been established. Hence, we hypothesized that CSF markers related to small vessel disease may also be applicable as biomarkers for BD. To investigate this hypothesis, we sampled CSF from 133 patients with BD and 86 healthy controls. The concentrations of neurofilament light chain (NF-L), myelin basic protein (MBP), S100B, and heart-type fatty acid binding protein (H-FABP) were measured in CSF and analyzed in relation to diagnosis, clinical characteristics, and ongoing medications. Hereby we found an elevation of the marker of subcortical axonal damage, NF-L, in bipolar subjects. We also identified positive associations between NF-L and treatment with atypical antipsychotics, MBP and lamotrigine, and H-FABP and lithium. These findings indicate axonal damage as an underlying neuropathological component of bipolar disorder, although the clinical value of elevated NF-L remains to be validated in follow-up studies. The associations between current medications and CSF brain injury markers might aid in the understanding of both therapeutic and adverse effects of these drugs.Keywords
This publication has 52 references indexed in Scilit:
- Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controlsBMC Psychiatry, 2013
- The association between cognitive function and white matter lesion location in older adults: a systematic reviewBMC Neurology, 2012
- Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1G93A Mice that Model ALSPLOS ONE, 2012
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- Long-term Antipsychotic Treatment and Brain VolumesArchives of General Psychiatry, 2011
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabAnnals of Neurology, 2010
- Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2009
- Subcortical Ischemic Vascular DementiaNeurologic Clinics, 2007
- Brain- and Heart-Type Fatty Acid-Binding Proteins in the Brain: Tissue Distribution and Clinical UtilityClinical Chemistry, 2004
- Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder*1Journal of Affective Disorders, 2004